- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, November 22, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A study entitled, “Geographic Variability of Medicaid Acceptance Among Allergists in the US,” published in the August 2024 issue of The American Journal of Managed Care® (AJMC®), was referenced in an article on Healio. According to the study, finding a provider who accepts a patient’s insurance was a barrier to accessing health care related to allergies, which could affect health outcomes in children with different allergies.
Two newsletters from NYU Langone Health referenced video interviews published on AJMC.com, the website of AJMC. The interviews, “Bridging Cancer Care Gaps and Overcoming Medical Distrust,” and “Uniting to Support Patients With Cancer Beyond Treatment,” featured interviews about topics covered during the Institute for Value-Based Medicine® event, which highlighted cancer care including overcoming mistrust and providing support to patients.
An article from TechTarget referenced an article published on AJMC.com. The article, “Reducing ‘Avoidable’ ED Visits for Mental Health Could Cut Billions in Costs, Improve Patient Outcomes,” reported that reducing visits to the emergency department for patients with mental health or substance abuse–related that could be treated elsewhere would save approximately $8.3 billion per year.
An article from AJMC entitled, “First Schizophrenia Treatment Approved in Decades Targets Cholinergic Receptors,” was referenced in an article from Psychiatric Times®. The article covered an FDA approval for xanomeline and trospium chloride capsules that marked the first treatment to target cholinergic receptors rather than dopamine receptors in adults with schizophrenia.
An article from Pharmacy Practice News referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “Senator Reintroduces Biosimilar Red Tape Elimination Act,” reported on the reintroduction of a bill by Sen Mike Lee (R, Utah), which would “end costly and time-consuming switching study requirements for companies to obtain interchangeability for biosimilars.”
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Cutting-Edge Eye Care Technologies Highlighted at SECO 2025
February 28th 2025Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes and clinical efficiency, as discussed during the keynote presentation at the Southeastern Congress of Optometry (SECO) 2025.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Understanding SMA Subtypes and the Impact of Treatment Advances
February 28th 2025The classification of spinal muscular atrophy (SMA) subtypes, the influence of SMN2 gene copies on disease severity, treatment effects on disease progression, age-related differences, long-term management strategies, and adequate muscle function monitoring are all important aspects of SMA care.
Read More
